# Mice with reduced expression of the telomere-associated protein Ft1 develop p53-sensitive progeroid traits

Mattia La Torre, Chiara Merigliano, Romina Burla, Carla Mottini, Giorgia Zanetti, Simona del Giudice, Mariateresa Carcuro, Ilaria Virdia, Elisabetta Bucciarelli, Isabella Manni, et al.

<figure><img src="image_1.png" /></figure>

## To cite this version:

Mattia La Torre, Chiara Merigliano, Romina Burla, Carla Mottini, Giorgia Zanetti, et al. Mice with reduced expression of the telomere-associated protein Ft1 develop p53-sensitive progeroid traits. Aging Cell, 2018, 17 (4), pp.e12730. 10.1111/acel.12730. pasteur-01768324

HAL Id: pasteur-01768324

https://pasteur.hal.science/pasteur-01768324

Submitted on 17 Apr 2018

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_3.png" /></figure>

ORIGINAL ARTICLE

# Mice with reduced expression of the telomere-associated protein Ft1 develop p53-sensitive progeroid traits

Mattia La Torre<fnref n="1" /> | Chiara Merigliano<fnref n="1" /> | Romina Burla<fnref n="1" /> | Carla Mottini<fnref n="1" /> |
Giorgia Zanetti<fnref n="1" /> | Simona Del Giudice<fnref n="1" /> | Mariateresa Carcuro<fnref n="1" /> | Ilaria Virdia<fnref n="2" /> |
Elisabetta Bucciarelli<fnref n="3" /> | Isabella Manni<fnref n="2" /> | Gianluca Rampioni Vinciguerra<fnref n="4" /> |
Giulia Piaggio<fnref n="2" /> | Mara Riminucci<fnref n="5" /> | Ana Cumano<fnref n="6" /> | Armando Bartolazzi<fnref n="4" /> |
Fiammetta Vernì<fnref n="1" /> | Silvia Soddu<fnref n="2" /> | Maurizio Gatti<fnref n="1" />,<fnref n="3" /> | Isabella Saggio<fnref n="1" />,<fnref n="3" />

Correspondence

Isabella Saggio and Maurizio Gatti,
Dipartimento di Biologia e Biotecnologie "C.
Darwin", Sapienza Università di Roma,
Rome, Italy.
Emails: isabella.saggio@uniroma1.it;
maurizio.gatti@uniroma1.it

Funding information

Progeria Research Foundation; Fondazione Telethon; Associazione Italiana per la Ricerca sul Cancro; EU FP7 Brainvectors, Grant/Award Number: 286071

Summary

Human AKTIP and mouse Ft1 are orthologous ubiquitin E2 variant proteins involved in telomere maintenance and DNA replication. AKTIP also interacts with A- and B-type lamins. These features suggest that Ft1 may be implicated in aging regulatory pathways. Here, we show that cells derived from hypomorph Ft1 mutant (Ft1kof/kof) mice exhibit telomeric defects and that Ft1kof/kof animals develop progeroid traits, including impaired growth, skeletal and skin defects, abnormal heart tissue, and sterility. We also demonstrate a genetic interaction between Ft1 and p53. The analysis of mice carrying mutations in both Ft1 and p53 (Ft1kof/kof; p53ko/ko and Ft1kof/kof; p53+/ko) showed that reduction in p53 rescues the progeroid traits of Ft1 mutants, suggesting that they are at least in part caused by a p53-dependent DNA damage response. Conversely, Ft1 reduction alters lymphomagenesis in p53 mutant mice. These results identify Ft1 as a new player in the aging process and open the way to the analysis of its interactions with other progeria genes using the mouse model.

KEYWORDS

aging, AKTIP, DNA damage, lamins, progeria, telomeres

1 | INTRODUCTION

Human AKTIP, mouse Ft1, and *Drosophila* Pendolino (Peo) are orthologous ubiquitin E2 variant proteins involved in telomere maintenance (Burla et al., 2015; Cenci, Ciapponi et al., 2015). AKTIP mediates proper telomere replication, binds telomeric DNA and the

shelterins TRF1 and TRF2, and interacts with the DNA replication machinery components PCNA and RPA70. We have previously suggested that AKTIP works in concert with TRF1 to facilitate telomeric DNA replication (Burla et al., 2015).

AKTIP also interacts with A- and B-type lamins and is enriched
at the nuclear rim (Burla, Carcuro, et al., 2016). Reduction in AKTIP

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.

© 2018 The Authors. *Aging Cell* published by the Anatomical Society and John Wiley & Sons Ltd.

<footnote n="1">¹Dipartimento di Biologia e Biotecnologie "C. Darwin", Sapienza Università di Roma, Rome, Italy</footnote>

<footnote n="2">²Dipartimento di Ricerca, Diagnostica Avanzata e Innovazione Tecnologica, Istituto Nazionale Tumori Regina Elena, Rome, Italy</footnote>

<footnote n="3">³Istituto di Biologia e Patologia Molecolari del CNR, Rome, Italy</footnote>

<footnote n="4">⁴Azienda Ospedaliera Sant'Andrea, Rome, Italy</footnote>

<footnote n="5">⁵Dipartimento di Medicina Molecolare, Sapienza Università di Roma, Rome, Italy</footnote>

<footnote n="6">⁶Lymphopoiesis Unit, Institut Pasteur, Paris, France</footnote>
in human fibroblasts results in senescent phenotypes, including the activation of the p53 pathway, nuclear deformity, heterochromatin alterations, and senescence. In addition, AKTIP reduction affects lamin A expression in human cells (Burla, Carcuro, et al., 2016). Altogether, the properties of AKTIP place this protein at the crossroad of multiple pathways that have been associated with progeroid phenotypes.

The Hutchinson-Gilford progeria syndrome (HGPS) is the best-characterized example of progeria, caused by a mutation in exon 11 of the *LMNA* gene leading to the production of a truncated form of lamin A (De Sandre-Giovannoli et al., 2003). Patients with HGPS develop multiorgan abnormalities, including skeletal defects and absence of subcutaneous fat. They show a limited growth and die in the teenage years, prevalently due to cardiovascular problems leading to infarction or stroke (Hennekam, 2006). Mouse models reflect several aspects of the human disease; the LAK1 model, for example, carrying the G608G mutation in the *LMNA* gene, is characterized by reduced lifespan and body weight, and skeletal and skin defects (Osorio, Navarro, et al., 2011).

The idea that lamins play a pivotal role in determining premature aging is also supported by the discovery of progeroid disorders different from HGPS. For example, restrictive dermopathy patients carry recessive mutations in the ZMPSTE24 gene, which encodes the proteolytic enzyme involved in lamin A maturation (Barrowman, Wiley, Hudon-Miller, Hrycyna & Michaelis, 2012). Also, in this case, a mouse model replicates the progeroid phenotype of the disease (Osorio, Ugalde, et al., 2011). A partial recovery of the ZMPSTE24⁻/⁻ phenotype is obtained by depletion of the tumor suppressor protein p53, pointing to a role of DNA damage in the pathophysiology of this progeria (Varela et al., 2005).

In addition to the *LMNA* gene, several genes involved in DNA metabolism have been implicated in progeroid syndromes. They include the *WRN* and *BLM* genes, which encode members of the RecQ DNA helicase family and are responsible for the Werner and Bloom syndromes, respectively (Bachrati & Hickson, 2003).

Telomere dysfunctions have also been linked to progerias. Dyskeratosis congenita, which is caused by mutations in telomere-related genes, has progeroid phenotypic traits (Dokal, 2011).

The involvement of AKTIP in telomere maintenance and regulation of lamin A (Burla et al., 2015; Burla, Carcuro, et al., 2016) prompted us to investigate whether this protein contributes to preventing premature aging. We thus generated mice bearing a mutation in the *Ft1* gene. We report here that *Ft1* mutant mice exhibit multiple progeroid traits, including impaired growth, skeletal and skin defects, and sterility. We also demonstrate an interplay between *Ft1* and *p53*. *Ft1* mutant mice carrying mutations in *p53* (*Ft1*¹⁰⁰kof/¹⁰⁰kof; *p53*¹⁰⁰kof/¹⁰⁰kof and *Ft1*¹⁰⁰kof/¹⁰⁰kof; *p53*¹⁰⁰kof/¹⁰⁰kof) showed a partial rescue of the progeroid traits observed in *Ft1* single mutants, suggesting that these traits are at least in part caused by the p53-mediated response to the DNA damage elicited by mutation in *Ft1*.

## 2 | RESULTS

### 2.1 | Generation of Ft1 kof mice and characterization of derived MEFs

Given that AKTIP is required for DNA replication and cell proliferation (Burla et al., 2015), we reasoned that full knockout (ko) of *Ft1* would cause physiological damage incompatible with mouse survival. Thus, we produced animals with reduced *Ft1* levels using the knockout first (kof) strategy, based on the insertion into the target gene (referred as kof allele) of the βgeok cassette (Testa et al., 2004) (Figure 1a), which traps and truncates *Ft1* nascent transcript reducing the expression of the gene (Figure 1a). Transgenic founders and subsequent generations were screened by PCR (Figure 1b), and two independent kof lines (lines 107 and 588) were selected and analyzed for mRNA reduction. q-PCR on tail biopsies from *Ft1*¹⁰⁰kof/¹⁰⁰kof and *Ft1*¹⁰⁰kof/¹⁰⁰kof animals showed that *Ft1* expression was significantly reduced compared to wild-type (wt) mice (Figure 1c). In *Ft1*¹⁰⁰kof/¹⁰⁰kof mice from lines 107 and 588, *Ft1* expression was reduced to 18% and 12%, respectively; in *Ft1*¹⁰⁰kof/¹⁰⁰kof animals from the same lines, *Ft1* expression was reduced to 64% and 52% (Figure 1c). The analysis of 573 F1 progeny from crosses between *Ft1*¹⁰⁰kof/¹⁰⁰kof conformed to Mendelian ratios, although we observed a slight nonsignificant trend of embryonic lethality of *Ft1*¹⁰⁰kof/¹⁰⁰kof animals (Figure 1d).

We next investigated whether MEFs from *Ft1*¹⁰⁰kof/¹⁰⁰kof mice exhibit the same phenotypes as those previously observed in RNAi cells depleted of AKTIP or *Ft1* (Burla et al., 2015; Burla, Carcuro, et al., 2016). We first checked the *Ft1* subcellular localization by immunostaining MEFs with an anti-*Ft1* antibody. In human cells, AKTIP is enriched at the nuclear rim where it partially co-localizes with lamins (Burla, Carcuro, et al., 2016). Consistent with these results, *Ft1*¹⁰⁰kof/¹⁰⁰kof MEFs displayed a *Ft1* signal at the nuclear periphery (Figure 1e), while the signal was undetectable in the *Ft1*¹⁰⁰kof/¹⁰⁰kof MEFs (Figure 1e,f). In line with these results, Western blotting showed a strong reduction of *Ft1* in *Ft1*¹⁰⁰kof/¹⁰⁰kof MEF extracts (Figure 1g).

We then asked whether MEFs from *Ft1*¹⁰⁰kof/¹⁰⁰kof mice activate the DNA damage response (DDR) and exhibit telomere defects. Compared to wt MEFs, *Ft1*¹⁰⁰kof/¹⁰⁰kof MEFs displayed substantial increases in 53BP1 and γH2AX foci, indicating that *Ft1* is required for the maintenance of genome integrity (Figure 2a-f). In addition, double immunofluorescence staining of γH2AX and TRF1 showed that *Ft1*¹⁰⁰kof/¹⁰⁰kof MEFs exhibit a significant increase in γH2AX/TRF1 co-labeled foci (Telomere Dysfunction induced Foci, TIFs) compared to control MEFs, suggesting that the DDR of mutant cells was at least in part linked to telomere dysfunction (Figure S1c,d). To determine the nature of telomere defects in *Ft1*¹⁰⁰kof/¹⁰⁰kof MEFs, we performed in situ hybridization with a TTAGGG probe. The analysis of meta-phase spreads showed that *Ft1*¹⁰⁰kof/¹⁰⁰kof MEFs exhibit multiple telomeric signals (MTS, also known as fragile telomeres) and sister telomere associations (STA) (Figure 2g-i and Figure S1e). These types of telomere aberrations are considered hallmarks of defective telomere replication (Sfeir et al., 2009). *Ft1*¹⁰⁰kof/¹⁰⁰kof MEFs showed a small but not
<figure><img src="image_4.png" /></figure>

**FIGURE 1** Generation of *Ft1*<sup>kof/kof</sup> mice. (a) wt allele (+) of *Ft1* and *kof* cassette inserted into the gene to generate animals with reduced *Ft1* expression. F, forward; R, reverse; Frt, target site for FLP recombinase; loxP, target site for Cre recombinase; SA, splicing acceptor site element from *engrailed* 2; IRES, internal ribosomal entry site from the Encephalomyocarditis virus; lacZ, β-galactosidase gene; neo, neomycin phosphotransferase, selectable marker. (b) PCR of gDNA from *Ft1*<sup>+/+</sup>, *Ft1*<sup>+/kof</sup>, and *Ft1*<sup>kof/kof</sup> animals. (c) q-PCR on tail cDNA of animals from two independent mouse lines. Results present the ratios between *Ft1* exons 6 and 3 normalized to GAPDH. *Ft1*<sup>kof/kof</sup> mice *n* = 53, *Ft1*<sup>+/kof</sup> animals *n* = 15, and wt *n* = 30. ***p* < .001 in Student's *t* test. (d) Mendelian distribution; no significant difference between observed and expected *Ft1*<sup>kof/kof</sup> genotypes (*p* = .056 χ<sup>2</sup> test). (e) MEFs stained with anti-Ft1 antibody (red in merges). Scale bar 5 µm. (f) Frequency of MEF nuclei showing Ft1 localization at the nuclear rim. Graphs show mean ± SEM; *n* = 50 cells; ***p* < .001 in Student's *t* test. (g) Western blotting on MEF extracts

statistically significant increase in telomere fusions compared to matched control MEFs. In addition, *Ft1*<sup>kof/kof</sup> MEFs displayed a frequency of telomeres with a TTAGGG signal comparable to that of control, confirming (Burla et al., 2015) that an impairment of the *Ft1* function does not result in telomere loss (Figure S1a,b).

Finally, we evaluated the status of lamin A in MEFs. Consistent with our previous results on human AKTIP (Burla, Carcuro, et al., 2016), wt cells displayed partial co-localization of lamin A with *Ft1* (Figure S1f). *Ft1*<sup>kof/kof</sup> MEFs cells showed an altered lamin A distribution with a reduced concentration of lamin A at the nuclear rim (Figure 2j–l).

Altogether, our results indicate that *Ft1*<sup>kof</sup> mutation cause DDR, telomere defects and abnormal lamin distribution, which are well-

known hallmarks of aging. We thus asked whether *Ft1*<sup>kof</sup> mutant mice exhibit signs of premature aging. In mouse models of progeroid disorders, premature aging alterations mostly affect body growth, fertility, bones, skin and heart. We therefore focused on these phenotypic traits in our analyses on *Ft1*<sup>kof</sup> mutant mice.

## 2.2 | *Ft1* kof mice display growth defects, reduced lifespan and sterility

Macroscopic observation of *Ft1*<sup>kof/kof</sup> mice revealed that mutant animals (*n* = 170) display a significant reduction in body weight compared to controls (Figure 3a–c); 21% of the animals showed a 30% reduction in body weight compared to controls; henceforth, we will
<figure><img src="image_5.png" /></figure>

<figure><img src="image_6.png" /></figure>

<figure><img src="image_7.png" /></figure>

<figure><img src="image_8.png" /></figure>

<figure><img src="image_9.png" /></figure>

<figure><img src="image_10.png" /></figure>

<figure><img src="image_11.png" /></figure>

<figure><img src="image_12.png" /></figure>

<figure><img src="image_13.png" /></figure>

<figure><img src="image_14.png" /></figure>

<figure><img src="image_15.png" /></figure>

<figure><img src="image_16.png" /></figure>

<figure><img src="image_17.png" /></figure>
**FIGURE 2** DNA damage, telomere aberrations and lamin A alterations in *Ft1*<sup>kof/kof</sup> MEFs. (a–c) Staining for anti-γH2AX (red in merges) in MEFs (a) and quantification (b, c). (d–f) Staining with anti-γH2AX (red in merges) in MEFs (d) and quantification (e, f). Graphs (b, c, e, f) show mean ± SEM; **p** < .01; ***p** < .001 in Student's t test. Scale bars 5 µm. (g) Partial DAPI-stained (red) metaphases from MEFs showing telomeric FISH signals (black and white; green in merges) including enlargement of single chromosomes with multiple telomeric signals (MTS). MTS are indicated by arrows. (h, i) MTS (h) and STA (i) frequencies in MEFs. Graphs show mean ± SEM; *p* < .05; **p** < .001 in χ² test. (j) Immunostaining for lamin A in MEF nuclei. Scale bar 5 µm. (k) Quantification of lamin A signal at nuclear rim in MEFs. Graphs show mean ± SEM; *p* < .05 in Student's t test from two independent experiments on two MEF cultures (n = 100 cells/culture). (l) Z stack projections and quantification showing the altered distribution of lamin A in *Ft1*<sup>kof/kof</sup> MEF nuclei. See also Figure S1

refer to these mice as severely affected *Ft1*<sup>kof/kof</sup> mice, abbreviated with SA *Ft1*<sup>kof/kof</sup> or SA mutant mice. By selecting a cohort of animals with a mild (non-SA) phenotype, we monitored body weight over a 100-week period and subdivided lifespan in three major intervals: young 3 < weeks < 20; juvenile 21 < weeks < 60; adult 61 < weeks < 100. We observed that the difference in body weight between wt and *Ft1*<sup>kof/kof</sup> animals significantly increases as mice age (Figure 3b,c). *Ft1*<sup>kof/kof</sup> mice had a reduced lifespan compared to wt, SA *Ft1*<sup>kof/kof</sup> animals died at day 12–14, while the remaining population displayed a median survival of 113 weeks (Figure 3d). We also observed reduced fertility in inbreeding; when *Ft1*<sup>kof/kof</sup> non-SA males were crossed with *Ft1*<sup>+/kof</sup> females, we did not observe any pregnancies (Figure 3e). Altogether, these observations show that *Ft1* expression is critical for mouse growth, survival and fertility.

## 2.3 | *Ft1* kof mice display skeletal alterations

Bone is altered in progeroid patients and mouse models for progeria syndromes (Bergo et al., 2002; Mounkes, Kozlov, Hernandez, Sullivan

& Stewart, 2003; Osorio, Navarro, et al., 2011). Radiographic analyses of whole skeletons were collected at day 12 from eight SA *Ft1*<sup>kof/kof</sup> mice and three wt animals. X-ray images showed reduced skeleton size, craniofacial dysmorphism (Figure 4a), and kyphotic spine curvature (Figure 4a,b). Long bones in SA mutant mice were 70% of wt, consistent with the overall body size reduction in *Ft1*<sup>kof/kof</sup> mice (Figure 4c). This difference is evident in the magnification of femur and tibia (Figure 4c). A reduction in size was also observed in tail vertebrae (Figure 4d). Radiographic analysis further showed that femurs and tibiae from *Ft1*<sup>kof/kof</sup> mice are less reflective than wt bones. Quantification of pseudocolored images from X-ray images revealed a statistically significant difference between *Ft1*<sup>kof/kof</sup> and wt mice, suggesting osteopenic defects in mutant animals (Figure 4e,f).

To further define bone tissue organization, we histologically analyzed sections from caudal vertebrae obtained from SA *Ft1*<sup>kof/kof</sup> mice. Hematoxilyn and eosin (H&E) staining showed differences in the growth plate of *Ft1*<sup>kof/kof</sup> animals compared to wt (Figure 4g), while the marrow cavity appeared regularly formed in mutant mice. The analysis of femur sections showed that *Ft1*<sup>kof/kof</sup> mice exhibit

<figure><img src="image_18.png" /></figure>

**FIGURE 3** Growth, lifespan, and fertility of *Ft1*<sup>kof/kof</sup> mice. (a) Pictures of age-matched mice showing body size differences between *Ft1*<sup>kof/kof</sup> animals and wt. (b) Body weight analysis during growth of *Ft1*<sup>kof/kof</sup> and wt. Student's t test ***p* < .001. (c) Δ(C)<sub>t</sub> in lifespan intervals showing that difference in body weight increases with mouse age; **p* < .001 in Student's t test. (d) Kaplan-Meier survival curve of *Ft1*<sup>kof/kof</sup> and wt mice; **p* < .001—log-rank—Mantel-Cox test. (e) Pups generated by mice of different genotypes. Whiskers represent the minimum and the maximum values and the boxes the 25th to the 75th percentile; median values are shown as a line within the boxes. *p* < .05; **p* < .001 in Student's t test. See also Table S2
<figure><img src="image_19.png" /><figcaption>**FIGURE 4** Bone alterations in *Ft1*<sup>kof/kof</sup> mice. (a) X-ray on total body of *Ft1*<sup>kof/kof</sup> and wt mice at day 12. Arrowheads indicate spine defects and craniofacial dysmorphisms in *Ft1*<sup>kof/kof</sup> animals. (b) Quantification of the angle formed by the cervical and thoracic vertebrae; ***p < .001 in Student's t test. (c) X-ray images of femurs and tibias from *Ft1*<sup>kof/kof</sup> and wt at day 12. (d) X-ray of tail and magnification of caudal vertebrae (dotted white box) of *Ft1*<sup>kof/kof</sup> and wt at day 12. (e, f) Pseudocolored femur images (e) and relative quantification (f) showing that X-ray absorption is lower in *Ft1*<sup>kof/kof</sup> as compared to wt. Student's t test, *p* < .05. (g) H&E-stained sections of caudal vertebrae (top) and femurs (bottom) of *Ft1*<sup>kof/kof</sup> and wt at day 12. (h, i) TRAP (h) and relative quantification (i) on femur sections shows no significant differences in TRAP-positive cells between *Ft1*<sup>kof/kof</sup> and matched wt (p = .67 Student's t test). See also Table S2</figcaption></figure>

regular columnar and conjugational cartilage, although slightly shorter than controls (Figure 4g). In mutant mice, newly formed bone trabeculae were also shorter, with a poorly defined osteoblastic

rim, as compared to wt (Figure 4h). TRAP cytochemistry did not reveal significant differences in osteoclast numbers relative to bone surfaces between *Ft1*<sup>kof/kof</sup> samples and controls, suggesting that the
osteopenic defects cannot be ascribed to increased osteoclastogenesis (Figure 4i).

Altogether, these results show that mutations in *Ft1* cause bone defects that partially phenocopy those observed in progeroid models caused by mutations in lamin coding genes or in genes involved in DNA metabolism (Bergo et al., 2002; Chen et al., 2012; Saeed et al., 2011).

## 2.4 | *Ft1 kof* animals display skin and heart alterations

Several studies have shown that skin and heart are typically altered in premature aging disorders associated with impaired DNA

metabolism, lamin, or telomere defects (Bergo et al., 2002; Cao & Hegele, 2003; Mounkes et al., 2003; Watson et al., 2013). We found that in *SA Ft1*<sup>kof/kof</sup> mice adipose tissue deposits are strongly reduced compared to age-matched controls (Figure 5a). The analysis on H&E-stained skin sections clearly showed the absence of subcutaneous fat layer in *SA* mutant animals, a defect similar to the skin defects described in mice carrying mutations in the lamin A coding gene (Mounkes et al., 2003) (Figure 5b).

The heart of *SA Ft1*<sup>kof/kof</sup> mice was smaller than in controls, with a reduction in size proportional to the overall body reduction (Figure 5c). In addition, analysis of H&E-stained hearts of *Ft1*<sup>kof/kof</sup> animals and wt mice showed a difference in tissue architecture. In

<figure><img src="image_20.png" /><figcaption>**FIGURE 5** Lipodystrophy and heart defects in *Ft1*<sup>kof/kof</sup> mice. (a) Pictures of skinned *Ft1*<sup>kof/kof</sup> and wt at day 12, showing loss of body fat (yellow dot circles) in *Ft1*<sup>kof/kof</sup> animals. (b) H&E-stained skin sections of *Ft1*<sup>kof/kof</sup> and wt at day 12 showing reduction in fat layer. (c) H&E-stained hearts from wt and *Ft1*<sup>kof/kof</sup> mice (top) at day 12, and magnification of the heart tissue (bottom). (d) Quantification showing that *Ft1*<sup>kof/kof</sup> hearts have a higher number of nuclei per area compared to wt; **p < .01 in Student's t test. (e) Images of γH2AX immunostaining of heart sections from wt and *Ft1*<sup>kof/kof</sup> mice at day 12. (f) Percentages of cells showing more than five γH2AX foci in the heart sections shown in e. Error bars indicate SEM; ***p < .001 in Student's t test. (g) q-PCR quantification of the p21 senescence marker expression in wt and matched *Ft1*<sup>kof/kof</sup> mice at day 12 and at 6 months after birth. *p < .05 and **p < .001 in Student's t test. See also Table S2**</figcaption></figure>
hearts of SA Ft1$^{kof/kof}$ animals, there was no apparent fibrotic tissue and the number of nuclei per area was higher than in wt hearts, suggesting an increase in the nuclear/cytoplasmic ratio (Figure 5c,d).

To gain additional insight into the origin of the defects detected in SA Ft1$^{kof/kof}$ hearts, we immunostained heart sections for γH2AX to reveal DNA damage foci. In mutant hearts, the frequency of cells with more than 5 foci was significantly higher than in controls, indicating DDR activation (Figure 5e,f). We also investigated whether mutant hearts express the p21 DDR and senescence marker to a higher extent than to control hearts. q-PCR analysis revealed that p21 is upregulated in heart extracts from both 12 days SA mutants and 6-month non-SA Ft1$^{kof/kof}$ mice compared to age-matched controls (Figure 5g).

Collectively, these results indicate that mutations in *Ft1* affect the skin and heart structural organization, and activate DDR and senescence pathways.

## 2.5 | p53 and Ft1 genetically interact

p21 is a potent inhibitor of cyclin-dependent kinase (CDK) that mediates p53-dependent cell cycle arrest in response to DNA damage; it has been shown that p21 is activated by p53. We thus asked whether p53 contributes to the phenotypic traits observed in Ft1$^{kof/kof}$ mice. To test this possibility, we generated Ft1;p53 double mutant using p53 ko mice (Jacks et al., 1994). Double-mutant mice were examined for several phenotypic traits, particularly those affected in Ft1$^{kof/kof}$ single mutants.

We first analyzed fertility of mutant animals. In contrast with Ft1$^{kof/kof}$ male mice that were sterile, Ft1$^{kof/kof}$; p53$^{+/ko}$ and Ft1$^{kof/kof}$; p53$^{ko/ko}$ male mice gave progeny when crossed to wt females, indicating that mutation in one or both p53 alleles rescues sterility (Figure 6a). We next examined body weight and survival; the body weight deficiency observed in Ft1$^{kof/kof}$ mice was rescued in Ft1$^{kof/kof}$;p53$^{+/ko}$ mutants at least until the 24th postnatal week. However, after the 31st week, the body weight of Ft1$^{kof/kof}$;p53$^{+/ko}$ mutants was reduced compared to controls, although to a lesser extent than in Ft1$^{kof/kof}$;p53$^{+/+}$ (Figure 6b). Interestingly, Ft1$^{kof/kof}$; p53$^{+/ko}$ animals did not exhibit an improvement in their viability as compared to Ft1$^{kof/kof}$;p53$^{+/+}$; rather, the double mutation resulted in additive lifespan reduction (Figure 6c).

Analysis of death causes revealed a further interplay between Ft1 and p53 (Figure 6d,e and Figure S3). Homozygosity for Ft1$^{kof}$ did not result in malignant tumors, and Ft1$^{kof}$ mutations were modestly cancer-protective in a p53 ko background (Table S1 and Figure S3). However, the simultaneous presence of mutations in Ft1 and of p53 loss induced multiorgan lymphomas (Figure 6d, Figure S3b–e), which were not observed in p53 mutant animals that exhibit lymphomas in single organs (Figure 6d, Figure S3f,g and Table S1). In addition Mice with reduced levels of Ft1, both in the presence or absence of p53, appeared to be sensitive to other pathologies, including hepatitis, bone marrow aplasia, peritonitis, nephritis, and pneumonia (Figure 6e, and Table S1 and Figure S3h,i). Thus p53 deficiency in Ft1$^{kof/kof}$ mutant mice rescues the sterility and the reduced body

weight phenotypes, but a concomitant deficiency of p53 and Ft1 affects lymphomagenesis.

## 2.6 | Ft1 mutant cells are sensitive to DNA damaging agents

The DDR foci observed in the MEFs and heart of Ft1$^{kof/kof}$ mice, and the telomeric aberrations found in Ft1$^{kof/kof}$ MEFs suggest that Ft1 mutant cells might be defective in DNA repair. To address this issue, we determined the sensitivity of Ft1$^{kof/kof}$ MEFs to DNA damaging agents. We exposed Ft1$^{kof/kof}$ MEFs to nonlethal doses of the radio-mimetic compound bleomycin, which creates DNA double-strand breaks (DSBs). Cell density assessment at 10 days after treatment showed that Ft1$^{kof/kof}$ MEFs are significantly more sensitive to the drug compared to passage-matched wt MEFs (Figure S4a). Increased sensitivity of Ft1$^{kof/kof}$ MEFs to DNA damage was also observed after treatment with hydroxyurea, which depletes the cells of dNTPs, generating stalled replication forks that can collapse into DSBs (Figure S4b). Notably, the reduction in cell density observed in Ft1$^{kof/kof}$ MEFs after bleomycin or hydroxyurea treatment was rescued by the presence of a single p53$^{ko}$ mutant allele in the Ft1$^{kof/kof}$ background (Figure 6f,g). In line with these results, the Western blotting analysis showed that nonmutagenized Ft1$^{kof/kof}$ MEFs accumulate both p21 and p53 and that this accumulation was significantly reduced in Ft1$^{kof/kof}$;p53$^{+/ko}$ MEFs (Figure 6h and Figure S5a,b). Consistent with the finding that p53 and p21 accumulation is associated with cell senescence and reduced proliferation (Ibrahim et al., 2013; Sharpless & Sherr, 2015), we observed a decrease in proliferation of Ft1$^{kof/kof}$ MEFs compared to wt MEFs. We also observed an excessive doublings of Ft1$^{kof/kof}$;p53$^{+/ko}$ MEFs with respect to Ft1$^{+/+}$;p53$^{+/ko}$ cells (Figure 6i). An increase in the proliferation rate of MEFs bearing mutation in p53 has been reported previously (Lang et al., 2004; Ma, Choudhury, Hua, Dai & Li, 2013).

Collectively, these results suggest that Ft1 deficiency renders cells more sensitive to DNA damaging agents, resulting in proliferation defects that are (over) rescued by the presence of a single p53$^{ko}$ mutant allele.

## 3 | DISCUSSION

Human progeroid syndromes and their related animal models have been instrumental to identify factors involved in normal human aging. The cellular defects found in progeroid diseases that also characterize normal human aging include DNA damage and genome instability, telomere attrition, epigenetic alterations of histones, aberrations in the nuclear lamina, and cell senescence (de Boer et al., 2002; Liu et al., 2005; Osorio, Ugalde, et al., 2011; Varela et al., 2005).

Here we analyzed the cellular, developmental, and physiological phenotypes of Ft1 mutant mice, focusing on traits related to the aging process. Importantly, our analysis of MEFs from Ft1$^{kof/kof}$ mice confirmed and extended our previous results obtained on the mouse
<figure><img src="image_21.png" /><figcaption>**FIGURE 6** *Ft1*<sup>kof/kof</sup> mouse phenotype is p53 sensitive. (a) Pups generated by animals bearing mutations in *Ft1* and/or *p53*; ***p < .001 in Student's t test. Whiskers represent the minimum and the maximum values observed for each mating and the boxes the 25th to the 75th percentile. (b) Body weight in *Ft1*<sup>kof/kof</sup> animals in the presence or absence of a null mutation in *p53*; note that loss of a single p53 allele dominantly rescues the *Ft1*-dependent body weight reduction; *p* < .05; **p* < .001 in Student's t test. (c) Survival of *Ft1*<sup>kof/kof</sup>;*p53<sup>+/ko</sup> mice is decreased compared to that of *Ft1*<sup>+/ko</sup>;*p53<sup>+/ko</sup> and *Ft1*<sup>+/+</sup>;*p53<sup>+/ko</sup> animals (*p* < .001—log-rank—Mantel-Cox test). (d, e) Case analysis on wt mice and mice bearing mutations in *p53* (*p53<sup>ko/ko</sup>*) and *Ft1*, showing that *Ft1* mutation impacts on lymphomagenesis and inflammatory conditions. See also Figure S3 and Table S1. (f, g) Cell survival response in MEFs from *Ft1*<sup>+/+</sup>;*p53<sup>+/+</sup>, *Ft1*<sup>kof/kof</sup>;*p53<sup>+/+</sup>, and *Ft1*<sup>kof/kof</sup>;*p53<sup>+/ko</sup> mice upon increasing doses of bleomycin (f) or hydroxyurea (HU) (g) showing that cells homozygous for mutations in *Ft1* and bearing a null mutation in *p53* (*p53<sup>+/ko</sup>*) are less sensitive to DNA damage than *Ft1* mutant cells bearing two wt copies of *p53*. Graphs show mean ± SEM; **p* < .01 in Student's t test. (h) Western blotting analysis of p21 and p53 expression in *Ft1*<sup>+/+</sup>;*p53<sup>+/+</sup>, *Ft1*<sup>kof/kof</sup>;*p53<sup>+/+</sup>, and *Ft1*<sup>kof/kof</sup>;*p53<sup>+/-</sup>. (i) Population doubling (pd), showing that *Ft1*<sup>kof/kof</sup> MEFs have a reduced pd compared to *Ft1*<sup>+/+</sup> cells; this phenotype is rescued by a *p53<sup>ko</sup>* mutation. Each dot represents the mean ± SEM of the cumulative pd at the indicated day; *p* < .05, **p* < .001 in Student's t test. See also Figures S4 and S5</figcaption></figure>

and human cells depleted of *Ft1* or AKTIP (Burla et al., 2015; Burla, Carcuro, et al., 2016). Specifically, we showed that *Ft1*<sup>kof/kof</sup> mutant MEFs exhibit fragile telomeres and sister telomere associations, TIFs,

DNA repair foci, increased sensitivity to bleomycin and hydroxyurea, and reduced cell proliferation. In addition, we confirmed that in *Ft1* mutant MEFs there is an alteration in lamin A, resulting in a strong
reduction in the lamin nuclear rim. Thus, *Ft1* mutant MEFs display many traits that have been previously observed in progeroid syndromes and progeroid animal models, as well as in normal human aging.

Consistent with the results on mutant MEFs, our analysis of *Ft1*<sup>kof/kof</sup> mutant animals detected progeroid phenotypes. *Ft1*<sup>kof/kof</sup> mice displayed multiple traits that have been previously observed in several progeroid models (Table S2). We found that *Ft1* mutant mice have reduced body weight, fertility defects, and reduced lifespan, as previously observed in models of laminopathies (Bergo et al., 2002; Osorio, Navarro, et al., 2011) and telomeropathies (Martínez et al., 2009). In addition, the growth defects of *Ft1*<sup>kof/kof</sup> mice were exacerbated with aging, suggesting that the effects of *Ft1* mutations intercept the normal aging-induced degeneration pathways. *Ft1*<sup>kof/kof</sup> mice also displayed skin and bone defects, which were previously observed in lamin mutant mice (Bergo et al., 2002; Mounkes et al., 2003; Osorio, Navarro, et al., 2011), in *Tert* ko animals (Rudolph et al., 1999), and in mice with reduced *Trf1* expression (Martínez et al., 2009). Skeletal alterations and lipodystrophy have been imputed to failures in the proliferation of mesenchymal stem cell progenitors, which are sensitive to lamin mutations and senescence (Scaffidi & Misteli, 2008). Mutant hearts were smaller than those of wt animals and showed a higher nuclear density compared to wt, with an increase in the nuclear/cytoplasmic ratio. In addition, we found that mutant hearts display DNA damage and activation of the DDR, and up-regulation of *p21* expression. The relationships between increased DNA damage and a change in nuclear density in the mutant hearts are unclear. A possible explanation is that DNA damage and the related inflammation process induce local cell reprogramming. This explanation is consistent with the observation that cellular reprogramming in vivo occurs following tissue injury (Yanger et al., 2013).

The fact that the organismal phenotypes observed in *Ft1* mutant animals have also been found in models specifically defective in lamin structure and/or expression, or bearing mutations in genes required for telomere maintenance or DNA repair, poses an interesting question. Which of the cellular phenotypes observed in *Ft1* mutant MEFs (defective lamin behavior, telomere dysfunction, DNA damage) is responsible for the organismal progeroid phenotypes? Answering this question is difficult because the traits that characterize *Ft1* mutants at the cellular level are deeply interconnected. For example, alterations in lamin function affect DNA replication and repair, epigenetic modification of chromatin and transcription (Gonzalo & Kreienkamp, 2015). Moreover, multiple interactions link telomeres to the lamin network, including the association of telomeres with the nuclear envelope (Burla, La Torre & Saggio, 2016). Finally, telomeres recruit and interact with many DNA repair factors, which play crucial functions in telomere maintenance (Doksani & de Lange, 2014). Thus, current information does not allow identification of the specific cellular phenotype that leads to progeroid traits observed in *Ft1* mutant mice. The most likely hypothesis is that all cellular defects observed in *Ft1* mutant MEFs contribute to the

organismal phenotype of mutant animals. It is indeed quite possible that these defects lead to senescence in most if not all tissues, causing developmental defects and infertility.

## 3.1 | Relationships between Ft1, p53, and cancer

We have shown that p53 deficiency in *Ft1* mutant MEFs induces cell over proliferation and rescues the sensitivity to both bleomycin and hydroxyurea. Consistent with these findings, in *Ft1*<sup>kof/kof</sup> mutant mice, mutations in *p53* rescue the body weight and sterility phenotypes but do not improve survival. Impairment of the p53 function also ameliorates the progeroid phenotypes in BRCA1-deficient mice (Cao, Li, Kim, Brodie & Deng, 2003) and in HGPS mouse models (Varela et al., 2005). However, p53 deficiency worsens the progeroid phenotype in telomere dysfunctional mice (Begus-Nahrmann et al., 2009). An explanation for this discrepancy is that p53 deficiency allows beneficial propagation of damaged cells rescuing certain progeroid traits. However, when cellular damage is extensive and the regenerative capacity of tissues is severely limited, p53 deficiency would become deleterious and accelerate aging (Lopez-Otin, Blasco, Partridge, Serrano & Kroemer, 2013). Our results are consistent with this model; they indicate that mutations in *Ft1* result in a relatively mild genomic damage that triggers DDR-related checkpoints, which are abolished by mutations in *p53* allowing resumption of cell proliferation.

The relationships between mutations in progeria-related genes and cancer are also complex. Progeroid models have been used to study the interplay between aging and cancer, given that age is a major risk factor for cancer developing. It has been shown that some forms of progeria can exert a protective role against tumor development (de la Rosa et al., 2013). On the other hand, mutations in the WRN helicase causing a segmental progeroid syndrome have been associated with an elevated cancer risk (Blander et al., 2000). We found that *Ft1*<sup>kof</sup> mutation does not induce cancer and that *p53 Ft1* double-mutant mice do not exhibit an increase in the overall frequency of malignancies. However, *p53* ko combined with *Ft1* deficiency induced an increase in the diffusion of lymphomas as compared to the restricted localization of this type of tumor in *p53* ko mice. It has been reported that T-cell lymphomas in *p53* ko mice are oligoclonal and generated by a characterized sequence of mutational events (Dudgeon et al., 2014). We therefore hypothesize that in *p53 Ft1* double mutants, this sequence is altered causing monoclonality and/or histotype change of lymphomas.

In conclusion, we have shown that mutations in *Ft1* affect lamin, telomeres, DNA repair, and cell senescence. At the organismal level, these mutations result in a number of phenotypes that have been previously observed in several progeria mouse models. Thus, we believe that *Ft1* is a new player in both the normal and accelerated aging processes, and that *Ft1* mutant mice will be instrumental to analyze the interactions between *Ft1* and other mouse progeria genes.
# 4 EXPERIMENTAL PROCEDURES

## 4.1 Mice

ES (HEPD0589_6_H06) from C57BI/6 animals carrying the knockout first mutations in the *Ft1* gene (referred as *Ft1 kof*) were generated by the International Knock-out mouse consortium. Injections into C57BI/6 blastocyst were performed in EMBL (Monterotondo, Italy). Chimeras were crossed with C57BI/6 and heterozygous animals backcrossed with C57BI/6 and/or intercrossed. *Ft1<sup>+/kof</sup>* were crossed with *p53<sup>+/ko</sup>* (Jacks et al., 1994) animals to obtain double mutants. Offspring were weaned at 3 weeks, and tail biopsies were genotyped and transgene expression analyzed. When needed, mice were anesthetized by intramuscular Zeoltil 20 (Virbac S.A., France), or euthanized by asphyxiation with carbon dioxide or cervical dislocation.

## 4.2 Cells

MEFs were isolated and cultured as described in Rinaldo et al. (2012). Population doubling (pd) was calculated with the formula Log (n<sub>t</sub>/n<sub>0</sub>) × 3.33. For Bleomycin and Hydroxyurea sensitivity assay, cells plated 24 hr in advance were treated with Bleomycin (Sanofi Aventis) or Hydroxyurea (Sigma) for 7 hr and replaced with medium w/o drugs. Cell density was calculated 10 days after treatment by staining with crystal violet (5% in methanol, Sigma) for 10 min and analyzed by *IMAGEJ*.

## 4.3 Genotyping

Tail biopsies were digested overnight at 56°C with a proteinase K/ SDS solution; genomic DNA (gDNA) was extracted using the NucleoSpin® Tissue columns kit (Macherey-Nagel, Duren, Germany) following manufacturer's instructions. Mice were PCR genotyped using the following primers:

* Ft1 E4 F: 5'-GTGAAGCAGAAGCTGCCAGGAGT-3'

* Ft1 E6 R: 5'-AGCTCACCCGAGGTGGGATCAA-3'

* p53-X6 F: 5'-AGCGTGGTGGTACCTTATGAGC-3'

* p53-Neo19 F: 5'-GCTATCAGGACATAGCGTTGGC-3'

* p53-X7 R: 5'-GGATGGTGGTATACTCAGAGCC-3'

## 4.4 q-PCR

RNA was extracted using the TRIzol reagent (Invitrogen) according to manufacturer, after DNasel treatment (Invitrogen) was reverse transcribed into cDNA with oligo d(T) primer and OMNISRIPT RT KIT (Qiagen). q-PCRs were performed as described (Burla et al., 2015) using following primers:

* Ft1 E3 F: AACCAGTCCTCCACGAAGTGCA;

* Ft1 E3 R: TAGGGCTTCGCTATGGGTAGAGCA;

* Ft1 E6 F: CCGTCTTTCACCCACTAGTTGAT;

* Ft1 E6 R: TTGCGAACGCTCTTTTCACA;

* mGAPDH F: GTGGCAAAGTGGAGATTGTTGCC;

* mGAPDH R: TGTGCCGTTGAATTTGCCGT;

* p21 F: 5'-TGTCTGAGCGGCCTGAAGAT-3'

* p21 R: 5'-CTGCGCTTGGAGTGATAGAA-3'

## 4.5 Western blotting

Western blotting was carried out as described in Burla et al. (2015). Filters were incubated with rabbit monoclonal anti-FT1 (Sigma HPA 046300), rabbit anti-actin HRP-conjugated (C-11; Santa Cruz—sc1615), rabbit anti-p21 (C-19; Santa Cruz—sc397), and rabbit anti-p53 antibodies produced by S. Soddu as described in Cecchinelli et al. (2006). Filters were incubated with appropriate HRP-conjugated secondary antibodies (Santa Cruz).

## 4.6 Immunostaining, FISH, and cytology

For immunostaining, cells were fixed with 3.7% formaldehyde for 10 min at 4°C and permeabilized with 0.25% Triton X-100 in PBS for 5 min. Where indicated, cells were prepermeabilized according to (Burla et al., 2015). Cells were then incubated with the following antibodies in the presence of 3% BSA: anti-53BP1 (Novus Biologicals NB100-304), anti-γH2AX (05-636 clone JBW301 Upstate Biotechnology), anti-Trf1 (Abcam 1423), anti-Ft1 (Sigma, HPA 046300), and anti-Lamin A (H102, Santa Cruz Biotechnology sc 20680). Primary antibodies were detected with the pertinent secondary antibodies: anti-rabbit-ALEXA 555 (Invitrogen A21430) or anti-goat-FITC (Jackson Immunoresearch 705-095-003). FISH was carried out according to Burla et al. (2015). Cytological preparations were examined with a Carl Zeiss (Thornwood, NY) Axioplan fluorescence microscope equipped with an HBO100W mercury lamp and a cooled charged-coupled device (CCD camera; Photometrics CoolSnap HQ). Optical sections were captured at 0.3 µm Z steps using a Prior Proscan stepping motor with an EM-CCD camera (Cascade II, Photometrics) connected to a spinning-disk confocal head (Carvll, Beckton Dickinson) mounted on an inverted microscope (Eclipse TE2000S, Nikon). Each image is a maximum-intensity projection of all sections. Images were recorded using *METAMORPH* software package (Universal Imaging) and processed using *IMAGEJ* (http://imagej.nih.gov) and Adobe Photoshop.

## 4.7 Histology, immunohistochemistry, and TRAP

Skin, bone, and heart were fixed in 4% formaldehyde. Tissues were cleared with ascendant alcohol concentration, embedded in paraffin, and sectioned at 3.5 µm. Sections were hydrated with ascendant alcohol concentration, stained with Hematoxylin (Carlo Erba) and Eosin (Sigma), cleared, and mounted with DPX Mountant for Histology (Sigma). For γH2AX analysis on paraffin, embedded heart sections were treated as previously described (Martinez, Ferrara-Romeo, Flores & Blasco, 2014). Tissues were incubated overnight with an anti-γH2AX (Abcam 2893) diluted in BSA 3%, Triton X-100 0.1%, and the day after incubated for 1 hr at room temperature with the
pertinent secondary antibody (anti-rabbit-ALEXA 555, Invitrogen A21430). Slides were counterstained with Mayer hematoxilin (Carlo Erba) and mounted with DPX mounting solution for microscopic evaluation (Sigma). Pictures were taken with ZEISS-Axio Phot (Zeiss) microscope connected to Progress-C5 JENO-PTIK camera with the software PROGRESS MAC (Capture PRO). TRAP staining was performed according to manufacturer's instructions (Sigma 387A).

## 4.8 | X-ray and bone density analysis

Total body X-ray images were taken using Faxitron MX-20 (Faxitron X-ray Corp.) at 24 kV for 6 s; images captured with Medical Imaging Film HM Plus (Ferrania). Cervical-thoracic vertebrae angle quantification was measured with Photoshop CS6 plugin. Femurs were imaged using a Faxitron MX20 operating at 24 kV for 4 s. Image density was determined as previously described (Bassett, van der Spek, Gogakos & Williams, 2012).

## 4.9 | Statistics

Kaplan-Meier curves were analyzed using the log-rank (Mantel-Cox) test. Inheritance of *kof* allele was analyzed using the Mendelian ratio for heterozygous mating, and $\chi^2$ test was applied. The Kolmogorov-Smirnov test was used to compare gray-level cumulative frequency distributions in X-ray image quantification. Independent data sets were compared with the Student's t test (unpaired, two-tailed).

## ACKNOWLEDGMENTS

This work has been supported by Grants EU FP7 Brainvectors (no. 286071), Telethon GEP15033 and PRF 2016-67 to IS; by AIRC IG 2014 to MG. This work is in the memory of P. Bianco.

## CONFLICT OF INTEREST

We have no conflict of interest.

## AUTHOR CONTRIBUTIONS

MLT, CM, RB, GZ, SDG, MC, IV, EB, AB, IM, and GRV performed the experiments. MR, AC, FV, SS, MG, and GP contributed to the design of the experiments and to the writing of the manuscript. IS designed the experiments and wrote the manuscript.

## REFERENCES

* Bachrati, C. Z., & Hickson, I. D. (2003). RecQ helicases: Suppressors of tumorigenesis and premature aging. *Biochemical Journal*, **374**, 577–606. https://doi.org/10.1042/bj20030491

* Barrowman, J., Wiley, P. A., Hudon-Miller, S. E., Hrycyna, C. A., & Michaelis, S. (2012). Human ZMPSTE24 disease mutations: Residual proteolytic activity correlates with disease severity. *Human Molecular Genetics*, **21**, 4084–4093. https://doi.org/10.1093/hmg/dds233

* Bassett, J. H., van der Spek, A., Gogakos, A., & Williams, G. R. (2012). Quantitative X-ray imaging of rodent bone by Faxitron. *Methods in

* Molecular Biology*, **816**, 499–506. https://doi.org/10.1007/978-1-61779-415-5

* Begus-Nahrmann, Y., Lechel, A., Obenauf, A. C., Nalapareddy, K., Peit, E., Hoffmann, E., ... Rudolph, K. L. (2009). p53 deletion impairs clearance of chromosomal-instable stem cells in aging telomere-dysfunctional mice. *Nature Genetics*, **41**, 1138–1143. https://doi.org/10.1038/ng.426

* Bergo, M. O., Gavino, B., Ross, J., Schmidt, W. K., Hong, C., Kendall, L. V., ... Young, S. G. (2002). Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. *Proceedings of the National Academy of Sciences USA*, **99**, 13049–13054. https://doi.org/10.1073/pnas.192460799

* Blander, G., Zalle, N., Leal, J. F., Bar-Or, R. L., Yu, C. E., & Oren, M. (2000). The Werner syndrome protein contributes to induction of p53 by DNA damage. *FASEB Journal*, **14**, 2138–2140.

* Burla, R., Carcuro, M., La Torre, M., Fratini, F., Crescenzi, M., D'Apice, M., ... Saggio, I. (2016). The telomeric protein AKTIP interacts with A- and B-type lamins and is involved in regulation of cellular senescence. *Open Biology*, **6**, 160103. https://doi.org/10.1098/rsob.160103

* Burla, R., Carcuro, M., Raffa, G. D., Galati, A., Raimondo, D., Rizzo, A., ... Saggio, I. (2015). AKTIP/Ft1, a new shelterin-interacting factor required for telomere maintenance. *PLoS Genetics*, **11**, e1005167. https://doi.org/10.1371/journal.pgen.1005167

* Burla, R., La Torre, M., & Saggio, I. (2016). Mammalian telomeres and their partnership with lamins. *Nucleus*, **7**, 187–202. https://doi.org/10.1080/19491034.2016.1179409

* Cao, H., & Hegele, R. A. (2003). LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670) but not in Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090). *Journal of Human Genetics*, **48**, 271–274. https://doi.org/10.1007/s10038-003-0025-3

* Cao, L., Li, W., Kim, S., Brodie, S. G., & Deng, C. X. (2003). Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform. *Genes & Development*, **17**, 201–213. https://doi.org/10.1101/gad.1050003

* Cecchinelli, B., Porrello, A., Lazzari, C., Gradi, A., Bossi, G., D'Angelo, M., ... Soddu, S. (2006). Ser58 of mouse p53 is the homologue of human Ser46 and is phosphorylated by HIPK2 in apoptosis. *Cell Death and Differentiation*, **13**, 1994–1997. https://doi.org/10.1038/sj.cdd.4401933

* Cenci, G., Ciapponi, L., Marzullo, M., Raffa, G. D., Morciano, P., Raimondo, D., ... Gatti, M. (2015). The analysis of pendolino (peo) mutants reveals differences in the fusigenic potential among *Drosophila* telomeres. *PLoS Genetics*, **11**, e1005260. https://doi.org/10.1371/journal.pgen.1005260

* Chen, C. Y., Chi, Y. H., Mutalif, R. A., Starost, M. F., Myers, T. G., Anderson, S. A., ... Jeang, K. T. (2012). Accumulation of the inner nuclear envelope protein Sun1 is pathogenic in progeric and dystrophic laminopathies. *Cell*, **149**, 565–577. https://doi.org/10.1016/j.cell.2012.01.059

* de la Rosa, J., Freije, J. M., Cabanillas, R., Osorio, F. G., Fraga, M. F., Fernandez-Garcia, M. S., ... Lopez-Otin, C. (2013). Prelamin A causes progeria through cell-extrinsic mechanisms and prevents cancer invasion. *Nature Communications*, **4**, 2268.

* De Sandre-Giovannoli, A., Bernard, R., Cau, P., Navarro, C., Amiel, J., Boccaccio, I., ... Levy, N. (2003). Lamin a truncation in Hutchinson-Gilford progeria. *Science*, **300**, 2055. https://doi.org/10.1126/science.1084125

* Dokal, I. (2011). Dyskeratosis congenita. *Hematology/the Education Program of the American Society of Hematology*, **2011**, 480–486.

* Doksani, Y., & de Lange, T. (2014). The role of double-strand break repair pathways at functional and dysfunctional telomeres. *Cold Spring Harbor Perspectives in Biology*, **6**, a016576. https://doi.org/10.1101/csh perspect.a016576

* Dudgeon, C., Chan, C., Kang, W., Sun, Y., Emerson, R., Robins, H., & Levine, A. J. (2014). The evolution of thymic lymphomas in p53 knockout mice. *Genes & Development*, **28**, 2613–2620. https://doi.org/10.1101/gad.252148.114
Gonzalo, S., & Kreienkamp, R. (2015). DNA repair defects and genome instability in Hutchinson-Gilford Progeria Syndrome. *Current Opinion in Cell Biology*, **34**, 75–83. https://doi.org/10.1016/j.ceb.2015.05.007

Hennekam, R. C. (2006). Hutchinson-Gilford progeria syndrome: Review of the phenotype. *American Journal of Medical Genetics. Part A*, **140**, 2603–2624. https://doi.org/10.1002/(ISSN)1552-4833

Ibrahim, M. X., Sayin, V. I., Akula, M. K., Liu, M., Fong, L. G., Young, S. G., & Bergo, M. O. (2013). Targeting isoprenylcysteine methylation ameliorates disease in a mouse model of progeria. *Science*, **340**, 1330–1333. https://doi.org/10.1126/science.1238880

Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994). Tumor spectrum analysis in p53-mutant mice. *Current Biology*, **4**, 1–7. https://doi.org/10.1016/S0960-9822(00)00002-6

Lang, G. A., Iwakuma, T., Suh, Y. A., Liu, G., Rao, V. A., Parant, J. M., ... Lozano, G. (2004). Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. *Cell*, **119**, 861–872. https://doi.org/10.1016/j.cell.2004.11.006

Liu, B., Wang, J., Chan, K., Tjia, W., Deng, W., Guan, X., ... Zhou, Z. (2005). Genomic instability in laminopathy-based premature aging. *Nature Medicine*, **11**, 780–785. https://doi.org/10.1038/nm1266

Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013). The hallmarks of aging. *Cell*, **153**, 1194–1217. https://doi.org/10.1016/j.cell.2013.05.039

Ma, X., Choudhury, S. N., Hua, X., Dai, Z., & Li, Y. (2013). Interaction of the oncogenic miR-21 microRNA and the p53 tumor suppressor pathway. *Carcinogenesis*, **34**, 1216–1223. https://doi.org/10.1093/carcin/bgt044

Martinez, P., Ferrara-Romeo, I., Flores, J. M., & Blasco, M. A. (2014). Essential role for the TRF2 telomere protein in adult skin homeostasis. *Aging Cell*, **13**, 656–668. https://doi.org/10.1111/acel.12221

Martínez, P., Thanasoula, M., Muñoz, P., Liao, C., Tejera, A., McNees, C., ... Blasco, M. A. (2009). Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice. *Genes & Development*, **23**, 2060–2075. https://doi.org/10.1101/gad.543509

Mounkes, L. C., Kozlov, S., Hernandez, L., Sullivan, T., & Stewart, C. L. (2003). A progeroid syndrome in mice is caused by defects in A-type lamins. *Nature*, **423**, 298–301. https://doi.org/10.1038/nature01631

Osorio F. G., Navarro C. L., Cadinanos J., Lopez-Mejia I. C., Quiros P. M., Bartoli C., ... Lopez-Otin C. (2011) Splicing-directed therapy in a new mouse model of human accelerated aging. *Science Translational Medicine*, **3**, 106ra107.

Osorio, F. G., Ugalde, A. P., Marino, G., Puente, X. S., Freije, J. M., & Lopez-Otin, C. (2011). Cell autonomous and systemic factors in progeria development. *Biochemical Society Transactions*, **39**, 1710–1714. https://doi.org/10.1042/BST20110677

Rinaldo, C., Moncada, A., Gradi, A., Ciuffini, L., D'Eliseo, D., Siepi, F., ... Soddu, S. (2012). HIPK2 controls cytokinesis and prevents tetraploidization by phosphorylating histone H2B at the midbody. *Molecular Cell*, **47**, 87–98. https://doi.org/10.1016/j.molcel.2012.04.029

Rudolph, K. L., Chang, S., Lee, H. W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999). Longevity, stress response, and cancer in

aging telomerase-deficient mice. *Cell*, **96**, 701–712. https://doi.org/10.1016/S0092-8674(00)80580-2

Saeed, H., Abdallah, B. M., Ditzel, N., Catala-Lehnen, P., Qiu, W., Amling, M., & Kassem, M. (2011). Telomerase-deficient mice exhibit bone loss owing to defects in osteoblasts and increased osteoclastogenesis by inflammatory microenvironment. *Journal of Bone and Mineral Research*, **26**, 1494–1505. https://doi.org/10.1002/jbmr.349

Scaffidi, P., & Misteli, T. (2008). Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. *Nature Cell Biology*, **10**, 452–459. https://doi.org/10.1038/ncb1708

Sfeir, A., Kosiyatrakul, S. T., Hockemeyer, D., MacRae, S. L., Karlseder, J., Schildkraut, C. L., & de Lange, T. (2009). Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. *Cell*, **138**, 90–103. https://doi.org/10.1016/j.cell.2009.06.021

Sharpless, N. E., & Sherr, C. J. (2015). Forging a signature of in vivo senescence. *Nature Reviews Cancer*, **15**, 397–408. https://doi.org/10.1038/nrc3960

Testa, G., Schaft, J., van der Hoeven, F., Glaser, S., Anastassiadis, K., Zhang, Y., ... Stewart, A. F. (2004). A reliable IacZ expression reporter cassette for multipurpose, knockout-first alleles. *Genesis*, **38**, 151–158. https://doi.org/10.1002/(ISSN)1526-968X

Varela, I., Cadinanos, J., Pendas, A. M., Gutierrez-Fernandez, A., Folgueras, A. R., Sanchez, L. M., ... Lopez-Otin, C. (2005). Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. *Nature*, **437**, 564–568. https://doi.org/10.1038/nature04019

Watson, L. A., Solomon, L. A., Li, J. R., Jiang, Y., Edwards, M., Shin-ya, K., ... Berube, N. G. (2013). Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span. *Journal of Clinical Investigation*, **123**, 2049–2063. https://doi.org/10.1172/JCI65634

Yanger, K., Zong, Y., Maggs, L. R., Shapira, S. N., Maddipati, R., Aiello, N. M., ... Stanger, B. Z. (2013). Robust cellular reprogramming occurs spontaneously during liver regeneration. *Genes & Development*, **27**, 719–724. https://doi.org/10.1101/gad.207803.112

## SUPPORTING INFORMATION

Additional Supporting Information may be found online in the supporting information tab for this article.

**How to cite this article:** La Torre M, Merigliano C, Burla R, et al. Mice with reduced expression of the telomere-associated protein Ft1 develop p53-sensitive progeroid traits. *Aging Cell*. 2018;e12730. https://doi.org/10.1111/acel.12730